文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

脓毒症患者血浆1-磷酸鞘氨醇与神经酰胺浓度呈负相关及其预测死亡的价值

Inverse Correlation Between Plasma Sphingosine-1-Phosphate and Ceramide Concentrations in Septic Patients and Their Utility in Predicting Mortality.
PubMed 文献 · Shock · 2019-01-01
一句话结论脓毒症患者血浆1-磷酸鞘氨醇降低而神经酰胺升高,两者联合分析预测脓毒症死亡的曲线下面积为0.95。

该研究检测脓毒症患者血浆1-磷酸鞘氨醇(S1P)与神经酰胺浓度,并探讨其与病情及预后的关系。与健康对照和ICU对照相比,脓毒症患者血浆S1P显著降低、神经酰胺显著升高(P<0.05),且S1P与神经酰胺浓度呈负相关(r=-0.36,P<0.05)。线性回归分析显示血浆S1P和神经酰胺不仅与序贯器官衰竭评估(SOFA)评分相关,还与循环单核细胞HLA-DR表达相关。受试者工作特征分析显示,S1P与神经酰胺联合分析预测脓毒症致死性的曲线下面积为0.95。脓毒症患者血小板鞘氨醇激酶活性及SphK1表达水平显著降低(P<0.05)。

要点

  • 与健康对照和ICU对照相比,脓毒症患者血浆S1P显著降低、神经酰胺显著升高(P<0.05)。
  • 脓毒症患者中血浆S1P浓度与神经酰胺浓度呈负相关(r=-0.36,P<0.05)。
  • S1P与神经酰胺联合分析预测脓毒症致死性的曲线下面积为0.95,优于单用SOFA评分或HLA-DR。
  • 脓毒症患者血小板鞘氨醇激酶活性及SphK1表达水平显著降低(P<0.05)。
  • 线性回归显示血浆S1P和神经酰胺与SOFA评分及循环单核细胞HLA-DR表达相关。

适用人群与场景

  • 脓毒症患者,与健康对照及ICU对照进行比较

研究设计与关键结果

  • 研究检测脓毒症患者血浆S1P与神经酰胺浓度(HPLC-ESI-MS/MS法),并以流式细胞术检测外周血单核细胞HLA-DR表达。
  • 与健康对照和ICU对照相比,脓毒症患者血浆S1P显著降低而神经酰胺显著升高(P<0.05)。
  • 脓毒症患者血浆S1P浓度与神经酰胺浓度呈负相关(r=-0.36,P<0.05)。
  • 线性回归分析显示血浆S1P和神经酰胺与SOFA评分及循环单核细胞HLA-DR表达相关。
  • 受试者工作特征分析(纳入S1P、神经酰胺、SOFA评分和HLA-DR)显示,S1P与神经酰胺联合分析预测脓毒症致死性的曲线下面积为0.95。
  • 脓毒症患者血小板鞘氨醇激酶活性及SphK1表达水平显著降低(P<0.05)。
  • 线性回归分析显示血小板鞘氨醇激酶活性与脓毒症患者血浆S1P浓度相关(r=-0.41,P=0.02),原文此处写作r=-0.41,与「正相关」的表述方向不一致。

证据类型、等级与局限

  • 证据类型:研究论文(病例对照式的比较研究,含健康对照与ICU对照)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为血浆S1P与神经酰胺联合分析能以高准确度预测脓毒症死亡(曲线下面积0.95)。
  • 作者认为血小板SphK1表达降低及随之而来的鞘氨醇激酶活性下降可能是脓毒症期间血浆S1P水平降低的原因。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The aim of this study was to investigate the correlation between plasma sphingosine-1-phosphate (S1P) and ceramide concentrations in sepsis, and the possible mechanisms for altered expression.

METHODS: Plasma S1P and ceramide concentrations were measured by HPLC-ESI-MS/MS. HLA-DR (human leukocyte antigen-DR) expression on peripheral blood mononuclear cells was examined by flow cytometry. Platelet sphingosine kinases 1/2 (SphK1/2) mRNA expression, protein content, and enzyme activities were determined by qRT-PCR, western blot, and commercial enzyme assay kits, respectively.

RESULTS: Compared with healthy and ICU controls, septic patients had significantly decreased plasma S1P but increased ceramide concentrations (P < 0.05). S1P concentration was negatively associated with the ceramide concentration in the septic patients (r = -0.36, P < 0.05). Linear regression analysis found that plasma S1P and ceramide were linked not only to sequential (sepsis-related) organ failure assessment (SOFA) score but also the HLA-DR expression on circulating monocytes. An receiver operating characteristic analysis, including S1P, ceramide, SOFA score and HLA-DR, showed integrated analysis of S1P and ceramide as the better powerful predictors of septic lethality with area under the curve value of 0.95. More importantly, we found the platelet SphKs activities and the expression levels of SphK1 were significantly decreased in septic patients (P < 0.05). Linear regression analysis revealed platelet SphKs activity was positively associated with the plasma S1P concentration of the septic patients (r = -0.41, P = 0.02).

CONCLUSIONS: Integrated analysis of plasma S1P and ceramide predict septic mortality with high accuracy. The decreased platelet SphK1 expression and subsequent reduced SphKs activity might be responsible for the decreased plasma S1P levels during sepsis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Wu X, Hou J, Li H, et al. Inverse Correlation Between Plasma Sphingosine-1-Phosphate and Ceramide Concentrations in Septic Patients and Their Utility in Predicting Mortality. Shock. 2019. PMID: 30080743. doi:10.1097/SHK.0000000000001229

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。